Liver function Tofacitinib and coagulation profile showed that the patients had liver failure. AFLP was diagnosed. Emergency lower segment caesarean section was performed and delivered two live babies. The umbilical cord blood of patients was collected immediately after delivery. Then UCBSC were isolated using Ficoll-Hypaque,
suspended in normal sodium, transfused into patients by intravenous. At the same time, cryopreserved allogeneic UC-MSC were recovered and proliferated. At postpartum 4 days, 8 days and 12 days, UC-MSC was suspended in normal sodium and transfused into patients by intravenous. Results: The hospitalization time of two patients was 40 days and 36 days respectively. The bilirubin and liver enzymes of
the patient started to decrease at post-treatment 14 days, and the liver function had returned to normal before when they discharged. The clinical evolution of maternal and child were favorable and no side effects were observed during the 1-year follow-up. Conclusion: These two cases PD-1/PD-L1 tumor indicate that USBSC and UC-MSC can be used in the treatment of AFLP. They may help to restore injured liver function in patients with AFLP. Key Word(s): 1. AFLP; 2. Umbilical Cord; 3. stem cells; Presenting Author: ZHU ZHITAI Corresponding Author: ZHU ZHITAI Affiliations: ying tan people’s hospital Objective: To explore the effect of probiotics in the treatment of patients with hepatic encephalopathy. Methods: 30 cases of patients with hepatic encephalopathy (excluding clinical IV stage), were randomly divided into treatment group and control group. Treatment group: routine liver
protection against hepatic coma therapy, oral or nasal feeding live bacillus cereus capsules (0.5/, 3 /d), Shea diabetes 10 ml/, 3 times /d; the control group: 2-hydroxyphytanoyl-CoA lyase conventional liver protecting against hepatic coma therapy, oral or nasal feeding lactulose diabetes 10 ml/, 3 /d. For 1 weeks. Results: Compared with the treatment group and control group, two in treating hepatic encephalopathy has good curative effect. But the two time in awake patients, reduce the blood ammonia level, there was significant difference (P < 0.05). Conclusion: Probiotics to improve the clinical symptoms of the patients with hepatic encephalopathy, lowering blood ammonia, has certain value, conducive to disease in patients with hepatic encephalopathy improvement. Key Word(s): 1. probiotics; Presenting Author: YULI SUN Additional Authors: BAODONG TANG Corresponding Author: BAODONG TANG Affiliations: The first affiliated hospital of Sun Yat-sen University Objective: To assess the efficacy of Bicyclol Tablets in the treatment of nonalcoholic fatty liver disease (NAFLD).